Telehealth & Digital Health

Ossium Health's groundbreaking study using banked bone marrow from deceased donors could solve the critical shortage of transplant matches for patients.

A new strategic partnership aims to dismantle commercialization hurdles, promising faster access to life-saving therapies for rare disease patients.

SPR Therapeutics unveils 12-month data at NANS 2026, showing its temporary SPRINT PNS system provides durable pain relief without a permanent implant.

With $287M in new funding, Corxel Pharmaceuticals aims to disrupt the obesity market with its oral GLP-1 drug, CX11, and a diverse cardiometabolic pipeline.

PulseSight's first-in-class gene therapy for dry AMD completes its Phase I trial, offering a novel approach to a leading cause of vision loss.

A new AI system scans IDs to identify high-risk individuals in real-time, but raises questions about the balance between hospital safety and privacy.

The virtual ABA therapy leader aims to slash costs and wait times with its AI platform that delivers results in 85% fewer hours than traditional methods.

An innovative absorbable implant shows promise in helping men regain continence faster after prostate cancer surgery, a major quality-of-life concern.

A new AAAHC-accredited surgery center in Tarzana offers advanced spine and joint care, reflecting a national trend toward safer, cost-effective procedures.

A new partnership promises up to 22% savings for employers by integrating deep pharmacy expertise, tackling one of healthcare's most complex challenges.

Machina Medical's novel hydrogel barrier, MFUSE, gains FDA clearance, promising to control severe bleeding in seconds and disrupt the hemostasis market.

For 10 years, McKesson's QCDR has helped oncologists navigate MIPS. Now, new measures aim to elevate patient care and prove the value of treatment.

Midwest retailer Meijer partners with WellSync to offer $29.99 virtual care visits with no insurance, challenging competitors like CVS and Walmart.

The nation's largest occupational health provider acquires four LA-area clinics, signaling a major consolidation push in California's competitive market.

Carrying the Alzheimer's gene, a longevity expert has turned himself into a public experiment, documenting his radical protocol to prevent the disease.

Corvus Pharmaceuticals is set to unveil pivotal early data for its novel eczema drug, soquelitinib, a moment analysts call a critical milestone.

Genmab's antibody drug epcoritamab is the first of its kind to slow cancer progression in a Phase 3 trial for R/R DLBCL, offering a new path for patients.

Crosswalk Therapeutics secures a key grant to develop a therapy targeting the debilitating skeletal disease in Morquio A, a challenge current treatments can't solve.

A new 26-storey tower will add 280 long-term care beds and modern clinics, funded by an innovative philanthropic model that could reshape Canadian healthcare.

As dementia rates soar, one AI firm is using subtle signals from speech and drawing to spot cognitive decline years earlier, moving healthcare toward prevention.